Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Jose, California 95112


The purpose of this study is to evaluate the Tablo Hemodialysis System when used In-Center by trained individuals and In-Home by trained Subjects.


Inclusion Criteria: - Subject has end stage renal disease (ESRD) adequately treated by maintenance dialysis achieving a Kt/V ≥ 1.2 and has been deemed stable for at least three months by his/her treating nephrologist. - Subject has a well-functioning and stable vascular access that allows a blood flow of at least 300 ml/min. Exclusion Criteria: - Life expectancy less than 12 months from first study procedure. - Subject has had a recent major cardiovascular adverse event within the last 3 months. - Subject has New York Class III or IV Congestive Heart Failure, or ejection fraction less than 30%. - Subject with fluid overload due to intractable ascites secondary to liver cirrhosis. - Subject has uncontrolled blood pressure. - Subject is intolerant to heparin. - Subject is seroreactive for Hepatitis B Surface Antigen. - Subject has an active, life-threatening, rheumatologic disease. - Subject has a history of adverse reactions to dialyzer membrane material. - Subject is expected to receive an organ transplant during the course of the study. - Subject has a life-threatening malignancy actively receiving treatment that would prevent successful completion of the study protocol.



Primary Contact:


Backup Contact:


Location Contact:

San Jose, California 95112
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.